The case in front of me: oxidation · liraglutide · Janoshik.
I have done this once and I suspect I got away with it rather than got it right.
For context: I keep records of every batch, every lot number and every result, so an answer that requires me to track something is fine.
What would you do, and what would you check afterwards?
Photograph anything unexpected before you touch it further; a photograph is the only evidence that survives.
Inspect the powder against both a white and a black background under good light. Discolouration, browning or a yellow tinge on a peptide that should be white is worth photographing before doing anything else.
Look for fibres, glass fragments and dark particulate in the cake. Glass is the one that matters and is usually a crimping or handling artefact rather than a synthesis one.
Container closure integrity depends on the crimp and stopper seating, which is why those are the first things checked in any incoming-goods inspection.
Crimp, stopper, label, contents. Light background and dark background.
HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.
Submit a sampleFounded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.
Visit GL BiochemAnswer first: inspect before you reconstitute, because after reconstitution you cannot distinguish a particle that arrived with the powder from one you introduced.
Melt-back at the stopper — a glassy ring where the cake meets the closure — indicates the cycle ran warm at the top of the vial. Cosmetic in most cases, informative always.
Check the aluminium crimp is fully seated with no lift at the edge, the flip-off cap has not been previously removed, and the stopper sits flush without a visible gap or dimple.
Visual inspection for particulate matter is a pharmacopoeial requirement for parenteral products and the standard technique uses both light and dark backgrounds.
Inspect before reconstitution. Afterwards you cannot tell whose particle it is.
The relevant principle is that anything you find before reconstitution is the supplier's, and anything you find after might be yours.
Weigh the vial if you have a scale reading to a milligram. It will not give you content, but a vial several tens of milligrams lighter than its siblings is a fill problem.
After reconstitution, hold against a light and look for haze, floaters or a Tyndall effect. A clear solution that goes clear on contact is what a well-made preparation looks like.
The lot code has to be on the vial. A code on the box ties nothing to anything.
Specifically, this is a two-minute procedure that resolves a large fraction of the questions people ask afterwards.
Check the fill looks proportionate to the label claim. Ten milligrams of peptide is a small volume of powder, but it is not nothing, and a vial that looks empty is worth a photograph.
Lot traceability to the primary container rather than to secondary packaging is a basic requirement of any documentation system worth the name.
A vial that passes inspection has passed a very weak test. It has not been verified.
Photograph anything unexpected before touching it further.
Start with the seal, the stopper and the label, in that order, and then look at the contents against a light and a dark background.
Confirm the lot code is physically on the vial and legible, and that it matches the certificate and the invoice. A code on the box only ties a certificate to a box.
Melt-back and collapse are documented lyophilisation cycle defects with well-described visual appearances.
Passing inspection is a weak result. It rules out the obvious and nothing else.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.